Amendment Description
Amendment Flag
Current Fiscal Year End Date
Document Period End Date
Document Type
Entity [Domain]
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Filer Category
Entity Public Float
Entity Registrant Name
Entity Central Index Key
Entity Common Stock, Shares Outstanding
Document Fiscal Year Focus
Document Fiscal Period Focus
Legal Entity [Axis]
Investment [Table Text Block]
Schedule of investments
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated Amortization
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less: accumulated depreciation
Acquired Finite-Lived Intangible Assets by Major Class [Axis]
Payments to Acquire Businesses, Net of Cash Acquired
Acquisition of Elan Drug Technologies, net of cash acquired
Additional paid-in capital
Additional Paid in Capital, Common Stock
Amortization of Financing Costs and Discounts
Amortization of original issue discount and offering costs
Amortization of offering costs and discount
Depreciation
Depreciation expense
Amortization and impairment of acquired intangible assets
Amortization of Intangible Assets
Asset Retirement Obligation [Abstract]
Asset Retirement Obligations
Asset Retirement Obligation, Accretion Expense
Accretion expense
Asset Retirement Obligations, Noncurrent
Asset retirement obligation
Asset Retirement Obligation
Balance at the beginning of the period
Balance at the end of the period
CONSOLIDATED BALANCE SHEETS
Business Acquisition, Cost of Acquired Entity, Purchase Price
Total purchase price
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned
Value of ordinary shares issued as consideration in the acquisition
Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net
Total
Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents
Cash
Business Acquisition, Purchase Price Allocation, Current Assets, Inventory
Inventory
Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets
Prepaid expenses and other current assets
Business Acquisition, Purchase Price Allocation, Current Assets, Receivables
Receivables
Business Acquisition, Purchase Price Allocation, Current Liabilities
Accounts payable and accrued expenses
Business Acquisition, Purchase Price Allocation, Goodwill Amount
Goodwill
Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets
Other assets
Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment
Property plant and equipment
Business Acquisition [Axis]
Business Acquisition [Line Items]
Acquisitions
Schedule of Business Acquisitions, by Acquisition [Table]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
CASH AND CASH EQUIVALENTS - Beginning of period
CASH AND CASH EQUIVALENTS - End of period
Cash equivalents
Cash Equivalents [Member]
Interest Paid
Cash paid for interest
Certificates of Deposit [Member]
Certificates of deposit
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Accounts payable and accrued expenses
Valuation Allowance, Deferred Tax Asset, Change in Amount
Decrease in the valuation allowance due to the utilization of NOLs
Increase (Decrease) in Receivables
Receivables
COMMITMENTS AND CONTINGENCIES
Commitments and Contingencies Disclosure [Text Block]
Common stock, shares authorized
Common Stock, Shares Authorized
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Common Stock
Common Stock, Value, Issued
Components of Deferred Tax Assets and Liabilities [Abstract]
Components of the company's net deferred tax liabilities
COMPREHENSIVE LOSS
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Concentration Risk, Percentage
Concentration risk percentage
Concentration Risk by Type [Axis]
Concentration Risk [Line Items]
Concentrations
Concentration Risk [Table]
Corporate Debt Securities [Member]
Corporate debt securities
Cost of goods manufactured and sold
Cost of Goods Sold
Credit Concentration Risk [Member]
Receivables
CURRENT LIABILITIES:
Liabilities, Current [Abstract]
Total current liabilities
Liabilities, Current
Customer Concentration Risk [Member]
Revenue
Long-term Debt, Gross
Total
Aggregate principal amount of debt issued
Debt Instrument, Increase, Additional Borrowings
Face amount of term loan facility
Debt Instrument, Interest Rate, Effective Percentage
Yield to maturity rate (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Stated interest rate (as a percent)
Debt Instrument, Periodic Payment, Principal
Required quarterly principal payments
Scheduled principal payment
Debt Instrument, Unamortized Discount
Original issue discount
Debt Instrument [Line Items]
Long-term debt
Schedule of Long-term Debt Instruments [Table]
Deferred Income Tax Expense (Benefit)
Deferred income taxes
Deferred federal and state tax benefit
Deferred income tax (benefit) provision
Deferred Tax Assets, Deferred Income
Deferred revenue
Deferred Tax Assets (Liabilities), Net
Net deferred tax liabilities
Deferred tax liability related to acquired intellectual property
Deferred Tax Assets, Net
Total deferred tax assets
Deferred Tax Assets, Other
Other
Deferred Tax Assets, Tax Credit Carryforwards
Tax credit carryforwards
Deferred Tax Assets, Valuation Allowance
Less: valuation allowance
Deferred Tax Liabilities [Abstract]
Deferred tax liabilities :
Deferred Tax Liabilities, Goodwill and Intangible Assets, Intangible Assets
Intangible assets
Deferred tax liability related to acquired intellectual property
Deferred Tax Liabilities
Total deferred tax liabilities
Deferred revenue - current
Deferred Revenue, Current
Deferred revenue, short-term
DEFERRED REVENUE - LONG-TERM
Deferred Revenue, Noncurrent
Deferred revenue, long-term
Defined Contribution Plan, Cost Recognized
Employer contribution
Derivative, Number of Instruments Held
Number of contracts
Derivative Assets
Interest rate cap contracts
DERIVATIVE INSTRUMENTS
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Derivative Instruments Not Designated as Hedging Instruments, Loss
Loss on derivative instrument due to decreased in value of the contract
Derivative [Line Items]
Derivative instruments
Risk-management instruments
Derivative [Table]
ACQUISITIONS
Business Combination Disclosure [Text Block]
Diluted (in dollars per share)
Earnings Per Share, Diluted
Income (Loss) from Equity Method Investments
Reduction in carrying value of investment of the entity, which represents the Company's share of investee's net losses
Effective Income Tax Rate, Continuing Operations
Effective tax rate (as a percent)
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Reconciliation of the company's federal statutory tax rate to its effective rate
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance
Change in valuation allowance (as a percent)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate
Statutory federal rate (as a percent)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other
Other permanent items (as a percent)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development
Research and development benefit (as a percent)
Effective Income Tax Rate Reconciliation, Other Adjustments
Other (as a percent)
Effective Income Tax Rate Reconciliation, State and Local Income Taxes
State income taxes, net of federal benefit (as a percent)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount
Share based compensation expense capitalized
Allocated Share-based Compensation Expense
Total share-based compensation expense
Compensation cost recognized
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation Expense
Share-based Compensation
Share-based compensation expense
Equity Method Investments
Carrying value of equity investment
Equity Method Investment, Ownership Percentage
Ownership percentage
Cost-method Investments, Aggregate Carrying Amount
Investment in Acceleron Pharma, Inc., a collaborative partner
Extinguishment of Debt, Amount
Redemption of the balance of the debt instrument
Domestic Country [Member]
Irish
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets
Schedule of Finite-Lived Intangible Assets by Major Class [Table]
Finite-Lived Intangible Assets, Amortization Expense
Amortization expense
Finite-Lived Intangible Assets, Future Amortization Expense
Expected amortization of intangible assets
Finite-Lived Intangible Assets, Weighted-Average Useful Life
Weighted Amortizable Life (in years)
Foreign Currency Translation [Abstract]
Foreign Currency
Foreign Government Debt Securities [Member]
International government agency debt securities
Gains (Losses) on Extinguishment of Debt
Loss on purchase of non-recourse RISPERDAL CONSTA secured 7% Notes
Premium paid on redemption of debt
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
INCOME TAXES
Income Tax Disclosure [Text Block]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets
Intangible Assets, Net (Excluding Goodwill)
INTANGIBLE ASSETS - NET
Net Carrying Amount
Finite-Lived Intangible Assets, Gross
Gross Carrying Amount
Finite-Lived Intangible Assets, Net [Abstract]
Finite-lived intangible assets:
Finite-Lived Intangible Assets, Net
Net Carrying Amount
Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]
Indefinite-lived intangible assets:
Indefinite-Lived Intangible Assets (Excluding Goodwill)
Net Carrying Amount
Interest expense
Interest Expense
Interest Rate Cap [Member]
Interest rate caps
Interest rate cap contracts
Interest Rate Swap [Member]
Interest rate swap contract
Interest rate swap
Inventory
Inventory, Net
Inventory
Land [Member]
Land
Leasehold Improvements [Member]
Leasehold improvements
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities and Equity [Abstract]
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities and Equity
Total liabilities
Liabilities
Licensing Agreements [Member]
Collaboration agreements
Long-term debt - current
Long-term Debt, Current Maturities
Less: current portion
Long-term Debt, Maturities, Repayments of Principal after Year Five
Thereafter
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months
2013
Long-term Debt, Maturities, Repayments of Principal in Year Five
2017
Long-term Debt, Maturities, Repayments of Principal in Year Four
2016
Long-term Debt, Maturities, Repayments of Principal in Year Three
2015
Long-term Debt, Maturities, Repayments of Principal in Year Two
2014
LONG-TERM DEBT
Long-term Debt, Excluding Current Maturities
Long-term debt
Marketable Securities [Abstract]
Total investments
INVESTMENTS - LONG-TERM
Marketable Securities, Noncurrent
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
Net reduction unrecognized tax benefits expected resolution of certain matters
Maturities of Long-term Debt [Abstract]
Scheduled maturities of Term Loans
Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge
Maximum hedge period for interest rate protection of debt (in years)
Money Market Funds [Member]
Money market funds
Net Cash Provided by (Used in) Financing Activities
Cash flows provided by (used in) financing activities
Net Cash Provided by (Used in) Investing Activities
Cash flows (used in) provided by investing activities
Net Cash Provided by (Used in) Operating Activities
Cash flows used in operating activities
Proceeds from (Repayments of) Notes Payable
Payment or purchase of non-recourse RISPERDAL CONSTA secured 7% notes
NET LOSS
Net loss
Net Income (Loss) Attributable to Parent
Cash and Cash Equivalents, Period Increase (Decrease)
NET DECREASE IN CASH AND CASH EQUIVALENTS
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New accounting pronouncements
New Accounting Pronouncements or Change in Accounting Principle [Table]
Total other expense, net
Nonoperating Income (Expense)
Other Noncash Expense
Other non-cash charges
Notional Amount of Derivatives
Notional value
Non-voting Common Stock
Nonvoting Common Stock [Member]
Operating Leases, Future Minimum Payments Due [Abstract]
Future minimum rental commitments under non-cancelable operating leases
Operating Leases, Future Minimum Payments Due, Current
2013
Operating Leases, Future Minimum Payments, Due in Five Years
2017
Operating Leases, Future Minimum Payments, Due in Four Years
2016
Operating Leases, Future Minimum Payments, Due in Three Years
2015
Operating Leases, Future Minimum Payments, Due in Two Years
2014
Operating Leases, Future Minimum Payments, Due Thereafter
Thereafter
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals
Less: estimated sublease income
Operating Leases, Future Minimum Payments Due
Total future minimum lease payments before estimated sublease income
Operating Leases, Rent Expense, Net [Abstract]
Rent expense related to operating leases
Operating Loss Carryforwards
Operating loss carryforwards
OPERATING LOSS
Operating Income (Loss)
Revenue recognized
Revenues
Revenue by region:
Unrealized gains (losses) on marketable securities
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax
Unrealized gains on marketable securities, net of tax of $372, $225 and $1,831 for the year ended March 31, 2012, 2011 and 2010, respectively
Unrealized losses on marketable securities:
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax [Abstract]
Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Tax
Less: Reclassification adjustment for losses included in net (loss) income
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Preferred stock, shares issued
Preferred Stock, Shares Issued
Proceeds from Issuance of Long-term Debt
Proceeds from the issuance of long-term debt
Proceeds from Sale and Maturity of Marketable Securities
Sales and maturities of investments
Proceeds from the sales and maturities of marketable securities
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from the sale of equipment
Proceeds from sale of property, plant and equipment
Proceeds from Stock Options Exercised
Cash received from option exercises
Property, Plant and Equipment, Gross
Subtotal
PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT, NET
Property, Plant and Equipment, Net
Total property, plant and equipment, net
Investment in Acceleron Pharmaceuticals, Inc.
Payments to Acquire Other Investments
Payments to Acquire Property, Plant, and Equipment
Additions to property, plant and equipment
Receivables
Receivables, Net, Current
Repayments of Long-term Debt
Principal payments of long-term debt
Payments for Repurchase of Common Stock
Purchase of ordinary shares for treasury
Research and Development Arrangement [Member]
IPR&D
In-process research and development
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Research and development revenue
Contracts Revenue
REVENUES:
Revenue, Net [Abstract]
Product sales, net
Sales Revenue, Goods, Net
Other
Other Revenue, Net
Total revenues
Revenue, Net
INVENTORY
Inventory Disclosure [Text Block]
Secured Debt [Member]
Term loan
Term loans
Investments - short-term
Available-for-sale Securities, Debt Securities, Current
Selling, general and administrative
Selling, General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value
Forfeited (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Nonvested at the beginning of the period (in dollars per share)
Nonvested at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Nonvested at the beginning of the period (in shares)
Nonvested at the end of the period (in shares)
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition
Weighted average period for unrecognized compensation cost expected to be recognized (in years)
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized
Unrecognized compensation cost
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value
Fair value of RSU's vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date
Expiration period (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period
Derived service period (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Vesting period (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
Shares of common stock available for issuance
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value
Aggregate intrinsic value of stock options exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Expired (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Forfeited (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Forfeited (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant-date fair value of stock options granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)
Outstanding at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Outstanding at the beginning of the period (in shares)
Outstanding at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Exercisable at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Exercisable at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Estimated dividend yield (as a percent)
Expected annual dividend yield (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation
Share-based compensation
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Short-term Investments [Member]
Short-term investments
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Significant Accounting Policies [Text Block]
State and Local Jurisdiction [Member]
State
U.S. State
CONSOLIDATED STATEMENTS OF CASH FLOWS
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY:
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Equity Note [Abstract]
SHAREHOLDERS' EQUITY
Stockholders' Equity Note Disclosure [Text Block]
GOODWILL AND INTANGIBLE ASSETS
Goodwill and Intangible Assets Disclosure [Text Block]
Supplemental Cash Flow Information [Abstract]
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Income Taxes Paid
Cash paid for taxes
CURRENT ASSETS:
Assets, Current [Abstract]
Total current assets
Assets, Current
Trademarks [Member]
Trademark
Treasury Stock [Member]
Treasury Stock
Treasury Stock, Shares, Retired
Cancellation of treasury stock (in shares)
US Government Debt Securities [Member]
U.S. government obligations
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations
Decreases due to lapse of statute of limitations
Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions
Additions based on tax positions related to prior periods
Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Unrecognized tax benefit that would effect effective tax rate
Unrecognized Tax Benefits
Balance at the beginning of the period
Balance at the end of the period
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Write off of Deferred Debt Issuance Cost
Charges relating to write-off of the unamortized portion of deferred financing costs
Director [Member]
Directors
Common Stock [Member]
Ordinary Shares
Construction in Progress [Member]
Construction in progress
PROPERTY, PLANT AND EQUIPMENT
Property, Plant and Equipment Disclosure [Text Block]
Property, Plant and Equipment, Useful Life, Maximum
Estimated useful life, maximum (in years)
Property, Plant and Equipment, Useful Life, Minimum
Estimated useful life, minimum (in years)
Property, Plant and Equipment, Useful Life, Average
Estimated useful life (in years)
Building and Building Improvements [Member]
Building and improvements
Property, Plant and Equipment, Disposals
Carrying value at the time of disposition
Research and development
Research and Development Expense
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Changes in the carrying amount of the company's asset retirement obligation
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Reconciliation of the beginning and ending amount of unrecognized tax benefits
Available-for-sale Securities, Debt Maturities, within One Year, Fair Value
Within 1 year
Available-for-sale Securities, Debt Maturities, after One Through Five Years, Fair Value
After 1 year through 5 years
Available-for-sale Securities, Debt Maturities, after Five Through Ten Years, Fair Value
After 5 years through 10 years
Available-for-sale Securities, Debt Maturities, without Single Maturity Date, Fair Value
Total
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract]
Available-for-sale, Estimated Fair Value
Available-for-sale Securities [Abstract]
Available-for-sale securities:
Held-to-maturity Securities, Debt Maturities, Fair Value [Abstract]
Held-to-maturity, Estimated Fair Value
Held-to-maturity Securities, Fair Value
Estimated Fair Value
Restricted Stock [Member]
Restricted stock units
Stock Options [Member]
Stock options
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Share-based compensation
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost
Share-based compensation (as a percent)
Held-to-maturity Securities, Debt Maturities, within One Year, Fair Value
Within 1 year
Held-to-maturity Securities, Debt Maturities, after One Through Five Years, Fair Value
After 1 year through 5 years
Held-to-maturity Securities, Debt Maturities, after Five Through Ten Years, Fair Value
After 5 years through 10 years
Held-to-maturity Securities, Debt Maturities, Fair Value
Total
TOTAL ASSETS
Assets
Interest income
Investment Income, Interest
OTHER LONG-TERM LIABILITIES
Other Liabilities, Noncurrent
Concentration Risk by Benchmark [Axis]
Held-to-maturity Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses
Gross Unrealized Losses, Less than One Year
Held-to-maturity Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Losses
Gross Unrealized Losses, Greater than One Year
SHARE-BASED COMPENSATION
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
DEFERRED TAX LIABILITIES - LONG-TERM
Deferred Tax Liabilities, Noncurrent
Fair Value, by Balance Sheet Grouping [Table]
Estimate of Fair Value, Fair Value Disclosure [Member]
Total
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated fair value of the Term Loans
Cash and Cash Equivalents, Fair Value Disclosure
Cash equivalents
Statement [Table]
Statement, Scenario [Axis]
Investments, Fair Value Disclosure
Estimated Fair Value
Derivative Financial Instruments, Liabilities, Fair Value Disclosure
Interest rate swap contract
Acquired Finite-lived Intangible Asset, Amount
Intangible assets acquired, finite-lived
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life
Estimated useful life of intangible assets acquired (in years)
Acquired Indefinite-lived Intangible Asset, Amount
Intangible assets acquired, indefinite-lived
ASSETS
Assets [Abstract]
Statement
Statement [Line Items]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Balance at the beginning of the period
Balance at the end of the period
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Roll forward of the fair value of the Company's investments whose fair value was determined using Level 3 inputs
Fair Value, Inputs, Level 1 [Member]
Level 1
Fair Value, Inputs, Level 2 [Member]
Level 2
Fair Value, Inputs, Level 3 [Member]
Level 3
SHAREHOLDERS' EQUITY
FAIR VALUE
Fair Value Disclosures [Text Block]
Capital Leased Assets, Gross
Fully depreciated equipment acquired under capital lease
Treasury stock, at cost (35,078 and 10,069,208 shares at March 31, 2012 and 2011, respectively)
Treasury Stock, Value
Business Acquisition, Cost of Acquired Entity, Purchase Price [Abstract]
Purchase price of the EDT business
Internal Revenue Service (IRS) [Member]
Federal
U.S. Federal
Basic (in dollars per share)
Earnings Per Share, Basic
Deferred Tax Assets, Net [Abstract]
Deferred tax assets :
Excess Tax Benefit from Share-based Compensation, Financing Activities
Excess tax benefit from share-based compensation
Stockholders' Equity, Period Increase (Decrease)
Indefinite-lived Intangible Assets by Major Class [Axis]
Preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Common stock, shares issued
Common Stock, Shares, Issued
Long-term Debt.
Total
Carrying Value
Deferred Revenue
Deferred revenue from milestone payment received prior to April 1, 2011
OTHER ASSETS
Other Assets, Noncurrent
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding
Goodwill, Period Increase (Decrease)
Amount of increase to goodwill related to the release of deferred tax valuation allowance
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Anitdilutive potential common equivalent shares excluded from calculation of net loss per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Denominator:
LOSS PER COMMON SHARE:
LOSS PER SHARE
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Purchase Commitment, Remaining Minimum Amount Committed
Open purchase order commitments
Increase (Decrease) in Other Operating Liabilities
Other long-term liabilities
Schedule of Equity Method Investments [Table]
LOSS BEFORE INCOME TAXES
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest
Loss before provision for income taxes
Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis]
Schedule of Equity Method Investment, Equity Method Investee, Name [Axis]
Schedule of Equity Method Investments [Line Items]
Equity method investment
Goodwill
GOODWILL
Goodwill recorded in connection with the acquisition of EDT
Class of Stock [Axis]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Schedule of Property, Plant and Equipment [Table]
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Treasury stock, shares
Treasury Stock, Shares
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax
Unrealized gains on marketable securities, tax
Property, Plant and Equipment by Type [Axis]
Property, Plant and Equipment [Line Items]
Property, plant and equipment
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]
Other income (expense), net
Other Nonoperating Income (Expense)
Total shareholders' equity
Stockholders' Equity Attributable to Parent
BALANCE
BALANCE
Deferred Tax Liabilities, Property, Plant and Equipment
Property, plant and equipment
PROVISION (BENEFIT) FOR INCOME TAXES
Income Tax Expense (Benefit)
Total tax benefit
Held-to-maturity Securities, Parenthetical Disclosure [Abstract]
Held-to-maturity securities:
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount [Abstract]
Held-to-maturity, Amortized Cost
Held-to-maturity Securities, Debt Maturities, within One Year, Net Carrying Amount
Within 1 year
Held-to-maturity Securities, Debt Maturities, after One Through Five Years, Net Carrying Amount
After 1 year through 5 years
Held-to-maturity Securities, Debt Maturities, after Five Through Ten Years, Net Carrying Amount
After 5 years through 10 years
Held-to-maturity Securities, Debt Maturities, Net Carrying Amount
Total
Preferred stock, par value, $0.01 per share; 50,000,000 and zero shares authorized; none issued and outstanding at March 31, 2012 and 2011, respectively
Preferred Stock, Value, Issued
US Government Agencies Debt Securities [Member]
U.S. government and agency debt securities
COMPREHENSIVE LOSS:
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Accounts Receivable [Member]
Accounts receivable
Statement, Equity Components [Axis]
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Retained Earnings [Member]
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Loss (Income)
Employee Stock Option [Member]
Stock Options
LONG-TERM DEBT
Long-term Debt [Text Block]
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Issuance of ordinary shares under employee stock plans
Stock Issued During Period, Value, Acquisitions
Issuance of common stock to Elan Corporation, plc in connection with the purchase of Elan Drug Technologies
Stock Issued During Period, Value, Conversion of Convertible Securities
Conversion of non-voting common stock to common stock
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Issuance of ordinary shares under employee stock plans (in shares)
Stock Issued During Period, Shares, Acquisitions
Issuance of common stock to Elan Corporation, plc in connection with the purchase of Elan Drug Technologies (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Exercised (in shares)
Stock Issued During Period, Shares, Conversion of Convertible Securities
Conversion of non-voting common stock to common stock (in shares)
Repurchase of common stock for treasury, at cost (in shares)
Treasury Stock, Shares, Acquired
Inventory, Finished Goods, Net of Reserves
Finished goods
Inventory, Work in Process, Net of Reserves
Work in process
Inventory, Raw Materials, Net of Reserves
Raw materials
Other Inventory, Net of Reserves
Consigned-out inventory
Stock Issued During Period, Shares, Period Increase (Decrease)
Deferred Finance Costs, Gross
Offering costs associated with issuance of debt
Offering costs
Statement, Geographical [Axis]
Business Acquisition, Purchase Price Allocation, Other Noncurrent Liabilities
Other long-term liabilities
COLLABORATIVE ARRANGEMENTS
Collaborative Arrangement Disclosure [Text Block]
EXPENSES:
Costs and Expenses [Abstract]
Total expenses
Costs and Expenses
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Non-cash investing and financing activities:
Repurchase of common stock for treasury, at cost
Treasury Stock, Value, Acquired, Cost Method
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Additional disclosures
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
Additional disclosures
COMMITMENTS AND CONTINGENCIES (Note 17)
Commitments and Contingencies
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]
Stock options expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Weighted average exercise price (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Aggregate intrinsic value of stock options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Aggregate intrinsic value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Weighted average remaining contractual term of stock options exercisable (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted average contractual remaining life (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Stock options expected to vest (in shares)
Available-for-sale Securities, Fair Value Disclosure
Available for sale securities
Estimated Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Weighted-average assumptions
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
Additional disclosures
Excess tax benefit from share-based compensation
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Products and Services [Axis]
Shares, Issued
BALANCE (in shares)
BALANCE (in shares)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangibles
Acquired identifiable intangible assets
Intangible assets acquired, total
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual
Revenues from acquired business
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual
Net income from acquired business
Business Combination, Pro Forma Information [Abstract]
Unaudited pro forma information
LOSS PER SHARE
Earnings Per Share [Text Block]
Business Combination, Acquisition Related Costs
Expenses related to acquisition
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING:
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
INVESTMENTS
Marketable Securities [Text Block]
Business Acquisition, Cost of Acquired Entity, Cash Paid
Cash paid for acquisition
Upfront payment in accordance with the merger agreement
Business Acquisition, Cost of Acquired Entity, Equity Interests Issued and Issuable
Equity consideration in accordance with the merger agreement
Major Customers [Axis]
Depreciation, Depletion and Amortization
Depreciation and amortization
Accounts Payable, Current
Accounts payable
Accounts payable and accrued expenses
Accounts Payable and Accrued Liabilities, Current
Total accounts payable and accrued expenses
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options
Proceeds from the issuance of ordinary shares for share-based compensation arrangements
Assets, Fair Value Disclosure
Assets, Total
Liabilities, Fair Value Disclosure
Liabilities, Total
Available-for-sale Securities, Gross Unrealized Gains
Gross Unrealized Gains
Operating Leases, Rent Expense, Net
Rent expense
Available-for-sale Securities, Amortized Cost Basis
Amortized Cost
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Share-based compensation
Noncash or Part Noncash Acquisition, Value of Liabilities Assumed
Purchased capital expenditures included in accounts payable and accrued expenses
Proceeds from Debt, Net of Issuance Costs
Net proceeds from issuance of debt
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
Investments transferred into Level 3
Accounting Standards Update 2010-13 [Member]
ASC 718
Accounting Standards Update 2010-17 [Member]
Accounting guidance related to the milestone method of revenue recognition adopted
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
THE COMPANY
INVESTMENTS
ACQUISITIONS
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Schedule of revenues by geographic location, as determined by the location of the customer, and the location of its long-term assets
Fair Value, Hierarchy [Axis]
Fair Value by Measurement Frequency [Axis]
Schedule of Change in Asset Retirement Obligation [Table Text Block]
Schedule of changes in the carrying amount of the company's asset retirement obligation
Schedule of Maturities of Long-term Debt [Table Text Block]
Scheduled maturities of Term Loans
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Schedule of future minimum rental commitments under non-cancelable operating leases
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of components of the company's net deferred tax liabilities
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of components of company's provision (benefit) for income taxes
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of reconciliation of the company's federal statutory tax rate to its effective rate
Schedule of Intangible Assets and Goodwill [Table Text Block]
Schedule of goodwill and intangible assets
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Summary of the Company's assets and liabilities measured at fair value on a recurring basis
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of accounts payable and accrued expenses
Schedule of Purchase Price Allocation [Table Text Block]
Purchase price allocation of assets acquired and liabilities assumed
Schedule of Inventory, Current [Table Text Block]
Schedule of inventories
COMMITMENTS AND CONTINGENCIES.
INCOME TAXES
GOODWILL AND INTANGIBLE ASSETS
FAIR VALUE
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
INVENTORY
LONG-TERM DEBT
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
Summary of time-vested RSU activity
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Summary of stock option activity
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of weighted-average assumptions
DERIVATIVE INSTRUMENTS
Held-to-maturity Securities, Amortized Cost before Other than Temporary Impairment
Amortized Cost
SHARE-BASED COMPENSATION.
Asset Retirement Obligations, Policy [Policy Text Block]
Asset Retirement Obligations
Pension and Other Postretirement Plans, Nonpension Benefits, Policy [Policy Text Block]
Employee Benefit Plans
Business Acquisition, Pro Forma Information [Table Text Block]
Schedule of unaudited pro forma information
Business Combinations Policy [Policy Text Block]
Business Acquisitions
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
Derivatives, Policy [Policy Text Block]
Risk-management instruments
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency
Goodwill and Intangible Assets, Policy [Policy Text Block]
Goodwill and Intangible Assets
Impairment or Disposal of Long-Lived Intangible Assets, Impairment, Policy [Policy Text Block]
Impairment of Long-Lived Assets
Income Tax, Policy [Policy Text Block]
Income Taxes
Inventory, Policy [Policy Text Block]
Inventory
Investment, Policy [Policy Text Block]
Investments
Property, Plant and Equipment, Policy [Policy Text Block]
Property, Plant and Equipment
Research and Development Expense, Policy [Policy Text Block]
Research and Development Expenses
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
Schedule of share-based compensation expense
Property, Plant and Equipment [Table Text Block]
Schedule of estimated useful life of property, plant and equipment
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Schedule of revenue and receivables from customers exceeding 10% of total in each category
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Share-Based Compensation
Summary of Income Tax Contingencies [Table Text Block]
Schedule of reconciliation of the beginning and ending amount of unrecognized tax benefits
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Roll forward of the fair value of the Company's investments whose fair value was determined using Level 3 inputs
Estimated fair value of term loans
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of potential common equivalent shares
Earnings Per Share, Policy [Policy Text Block]
Loss per Share
Stockholders' Equity, Policy [Policy Text Block]
Comprehensive Loss
Antidilutive Securities, Name [Domain]
Business Acquisition, Acquiree [Domain]
Class of Stock [Domain]
Concentration Risk Benchmark [Domain]
Concentration Risk Type [Domain]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]
Equity Component [Domain]
Equity Method Investee, Name [Domain]
Fair Value, Measurement Frequency [Domain]
Fair Value, Measurements, Fair Value Hierarchy [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Income Tax Authority [Domain]
Indefinite-lived Intangible Assets, Major Class Name [Domain]
Long-term Debt, Type [Domain]
Major Types of Debt and Equity Securities [Domain]
Major Types of Debt Securities [Domain]
Name of Major Customer [Domain]
Products and Services [Domain]
Property, Plant and Equipment, Type [Domain]
Scenario, Unspecified [Domain]
Segment, Geographical [Domain]
Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain]
Segment Reporting, Policy [Policy Text Block]
Segment Information
Stock Repurchase Program, Remaining Authorized Repurchase Amount
Value of shares available for repurchase pursuant to repurchase program
Stock Repurchase Program, Authorized Amount
Value of shares authorized under repurchase program
Schedule of Debt [Table Text Block]
Schedule of long-term debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value
Research and Development Expense [Member]
Research and development
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Segment Reporting [Abstract]
Segment Information
SUBSEQUENT EVENTS
Held-to-maturity Securities, Unrecognized Holding Gain
Gross Unrealized Gains
Type of Adoption [Domain]
Noncash or Part Noncash Acquisition, Investments Acquired
Investment in Civitas Therapeutics, Inc.
Operating Leases, Rent Expense, Sublease Rentals
Sublease income
Range [Axis]
Range [Domain]
Maximum [Member]
Maximum
Minimum [Member]
Minimum
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares
Ordinary shares issued as consideration in the acquisition
Business Acquisition, Pro Forma Revenue
Revenues
Business Acquisition, Pro Forma Net Income (Loss)
Net loss
Collaborative Arrangement [Member]
Collaboration Agreements
Stock Issued
Issuance of common stock used in the acquisition of Elan Drug Technologies
Derivative Instrument Risk [Axis]
Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]
Arrangements and Non-arrangement Transactions [Domain]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Collaborative arrangements
Debt Security [Axis]
Income Tax Authority [Axis]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Maximum
Expected option term, maximum (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum
Expected option term, minimum (in years)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected stock volatility, minimum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected stock volatility, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk-free interest rate, minimum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Risk-free interest rate, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period, Minimum
Minimum vesting period
Investments Classified by Contractual Maturity Date [Table Text Block]
The cost and fair value of available-for-sale and held-to-maturity securities by contractual maturity
Hedging Designation [Domain]
Investment Type Categorization [Domain]
Hedging Designation [Axis]
Schedule of Operating Leased Assets [Table]
Operating Leased Assets [Line Items]
Lease Commitments
Derivative, Cost of Hedge
Cost of interest rate cap
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses
Gross Unrealized Losses, Less than One Year
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Losses
Gross Unrealized Losses, Greater than One Year
Revenue Recognition [Abstract]
Revenue Recognition
Adjustments for New Accounting Pronouncements [Axis]
Investment Holdings [Line Items]
Investments
Investment Type [Axis]
Investment Holdings [Table]
Derivatives, Fair Value [Line Items]
Fair value of derivatives
Derivative Asset, Fair Value, Gross Asset
Asset derivative
Derivative Liability, Fair Value, Gross Liability
Liability derivative
Cost of Sales [Member]
Cost of goods manufactured and sold
Cash Flow Hedging [Member]
Designated as cash flow hedge
Not Designated as Hedging Instrument [Member]
Not designated as hedging instrument
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]
Summary of the effect of derivatives designated as hedging instruments on the consolidated statements of operations and comprehensive loss
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
Amount of Loss Recorded (Ineffective Portion)
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion
Amount Reclassified from Accumulated Other Comprehensive Loss into Earnings (Effective Portion)
Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion
Amount Recognized in Accumulated Other Comprehensive Loss (Effective Portion)
Derivative Contract Type [Domain]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Summary of fair value and presentation in the consolidated balance sheets for derivatives designated and not designated as hedging instruments
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Parent [Member]
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to cash flows from operating activities:
Long-term Debt, Type [Axis]
THE COMPANY
Nature of Operations [Text Block]
Accrued compensation
Due to Employees, Current
Interest Payable, Current
Accrued interest
Other Accrued Liabilities, Current
Accrued other
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable and accrued expenses
Segment, Geographical, Groups of Countries, Group One [Member]
Rest of world
Foreign
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
Impairment charge
Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net [Abstract]
Purchase price allocation of assets acquired and liabilities assumed
Business Acquisition, Purchase Price Allocation, Deferred Income Taxes, Asset (Liability), Net
Deferred tax liabilities
Increase (Decrease) in Operating Capital [Abstract]
Changes in assets and liabilities, excluding the effect of acquisitions:
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current income tax provision (benefit):
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Deferred income tax (benefit) provision:
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Components of company's (benefit) provision for income taxes
Net Cash Provided by (Used in) Financing Activities [Abstract]
CASH FLOWS FROM FINANCING ACTIVITIES:
Net Cash Provided by (Used in) Investing Activities [Abstract]
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Provided by (Used in) Operating Activities [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
OTHER EXPENSE, NET:
Nonoperating Income (Expense) [Abstract]
Unrealized losses on derivative contracts, net of tax
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax
Unrealized loss on cash flow hedge, net of tax of $(194)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
Unrealized loss on cash flow hedge, tax
Holding gains (losses), net of tax
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
Total unrealized losses included in comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Shareholders' Equity
Increase (Decrease) in Deferred Revenue
Deferred revenue
Schedule of Revenues from External Customers and Long-Lived Assets [Table]
Revenues from External Customers and Long-Lived Assets [Line Items]
Geographic Information
Long-Lived Assets
Total long-term assets by region:
Debt Instrument, Description of Variable Rate Basis
Variable rate base
Variable interest rate base
Debt Instrument, Basis Spread on Variable Rate
Interest rate, basis spread (as a percent)
Type of Arrangement and Non-arrangement Transactions [Axis]
Fair Value, Measurements, Recurring [Member]
Recurring basis
Treasury Stock, Retired, Cost Method, Amount
Cancellation of treasury stock
Debt Instrument, Fair Value Disclosure
Estimated Fair Value
Available-for-sale Securities, Debt Maturities, within One Year, Amortized Cost Basis
Within 1 year
Available-for-sale Securities, Debt Maturities, after One Through Five Years, Amortized Cost Basis
After 1 year through 5 years
Available-for-sale Securities, Debt Maturities, after Five Through Ten Years, Amortized Cost Basis
After 5 years through 10 years
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis
Total
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis [Abstract]
Available-for-sale, Amortized Cost
Prepaid Expenses and Other Current Assets
Represents the total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet.
Prepaid expenses and other current assets
Manufacturing and Royalty Revenues
Revenue earned during the period from the sale of goods manufactured and royalty revenues received related to the sale, leasing or otherwise lending to a third party the entity's rights or title to under certain license arrangements.
Manufacturing and royalty revenues
COLLABORATIVE ARRANGEMENTS
Document and Entity Information
Increase (Decrease) in Inventory, Prepaid Expenses and Other Assets
Inventory, prepaid expenses and other assets
Increase (Decrease) In Inventory, prepaid expenses and other assets.
Receipt of Company Stock for Purchase of Stock Options or to Satisfy Minimum Tax Withholding Obligations Related to Stock Based Awards, Value
Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards
This element represents Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards.
Receipt of Company Stock for the Purchase of Stock Options or to Satisfy Minimum Tax Withholding Obligations Related to Stock Based Awards, Shares
Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards (in shares)
This element represents Receipt of Alkermes' stock for the purchase of stock options or to satisfy minimum tax withholding obligations related to stock based awards.
Shares acquired by means of net share settlements, related to the vesting of employee stock options to satisfy withholding tax obligations
Payment of Non Recourse Product Secured Seven Percent Notes Principal Attributable to Original Issue Discount
Payment or purchase of non-recourse RISPERDAL CONSTA secured 7% notes attributable to original issue discount
Represents the payment for purchase of non-recourse RISPERDAL CONSTA secured 7 percent notes attributable to original issue discount.
Nonrecourse Secured Notes Principal
RISPERDAL CONSTA secured notes (as a percent)
Represents RISPERDAL CONSTA secured notes percentage, which is attributable to original issue discount.
Inventory Finished Goods Net of Reserves Located at Third Party Warehouse and Shipping Service Provider
Finished goods inventory located at third party warehouse and shipping service provider
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale, located at third party warehouse and shipping service provider.
Strategic Equity Investments [Member]
Strategic equity investments
Represents information pertaining to strategic equity investments in corporations and other legal entities represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants.
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 2 to Level 3
Number of investments transferred into level 2 from level 3
Represents the number of investments transferred into level 2 from level 3 of the fair value hierarchy.
First Lien Term Loan [Member]
First Lien Term Loan
Represents the First Lien Term Loan which is due on September 16, 2017 and is secured by a first priority lien on substantially all of the assets and properties of the company and the guarantors.
First Lien Term Loan, due September 16, 2017
First Lien Term Loan, due September 16, 2017
Second Lien Term Loan [Member]
Second Lien Term Loan
Represents the Second Lien Term Loan which is due on September 16, 2018 and is secured by a second priority lien on substantially all of the assets and properties of the company and the guarantors.
Second Lien Term Loan, due September 16, 2018
Schedule of Finite-Lived and Indefinite-Lived Intangible Asset by Major Class [Table]
Disclosure of the carrying value of finite-lived and indefinite-lived intangible assets, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in operations of a company.
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Intangible assets
Intangible Assets Excluding Goodwill Gross
Gross Carrying Amount
Sum of the gross carrying amounts of all intangible assets, excluding goodwill, before accumulated amortization as of the balance sheet date.
Minimum Number of Commercial Drug Products in Portfolio
Minimum number of commercial drug products in Company's diversified portfolio
Represents the minimum number of commercial drug products in portfolio.
Business Combination, Right to Receive Number of Shares Upon Cancellation of Outstanding Shares and Associated Rights of Predecessor Company
Right to receive number of shares upon cancellation of outstanding shares and associated rights
Represents the right to receive a number of shares upon cancellation of outstanding shares and associated rights of predecessor company in consideration for the business merger.
Percentage of Ownership Interest Held by Former Shareholders of Predecessor Company
Former shareholders ownership percentage in Alkermes, plc
Represents the percentage of ownership of common stock or equity participation held by the former shareholders of predecessor company in the entity upon business merger.
Percentage of Interest Held by Wholly Owned Subsidiary of Acquiree
Percentage of interest held by wholly owned subsidiary
Represents the percentage of ownership of common stock or equity participation held by the wholly owned subsidiary of acquiree in the entity upon business merger.
Proceeds and Realized Gain (Loss) on Marketable Securities [Table Text Block]
Proceeds from the sales and maturities of marketable securities, plus the resulting realized gains and losses
Tabular disclosure of the proceeds from sales and maturities of marketable securities, plus the resulting realized gains and losses.
Long-term Investments [Member]
Long-term investments
Represents information pertaining to long-term investments.
Strategic Investments [Member]
Strategic investments
Represents information pertaining to strategic investments.
Marketable Securities at Amortized Cost
Amortized Cost
Represents the cost of debt and equity securities, which are categorized as held-to-maturity, trading securities and available-for-sale, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
Marketable Securities Gross Unrealized Gains
Gross Unrealized Gains
Represents the gross unrealized gains for securities, at a point in time, which are categorized as held-to-maturity, trading securities and available-for-sale securities.
Marketable Securities Continuous Unrealized Loss Position Less than 12 Months Aggregate Losses
Gross Unrealized Losses, Less than One Year
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for less than twelve months for those securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Marketable Securities Continuous Unrealized Loss Position 12 Months or Longer Aggregate Losses
Gross Unrealized Losses, Greater than One Year
Represents the excess of amortized cost basis over the fair value of securities that have been in a loss position for twelve months or longer for those securities that are categorized as held-to-maturity, trading securities and available-for-sale.
Marketable Securities Realized Gain
Realized gains
Represents the profit realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale.
Marketable Securities Realized Loss
Realized losses
Represents the loss realized on the sale of debt or equity securities categorized as held-to-maturity, trading securities and available-for-sale.
Civitas Therapeutics Inc [Member]
Civitas
Represents information pertaining to Civitas Therapeutics, Inc.
Equity Method Investee Preferred Stock Shares Issued
Shares of Series A preferred stock issued
Represents the total number of preferred shares issued by the equity method investee.
Equity Method Investee Proceeds from Preferred Stock Shares Issued
Proceeds from issuance of shares of Series A preferred stock
Represents the proceeds from issuance of preferred shares issued by the equity method investee.
Equity Method Investment Percentage of Preferred Stock Shares Received
Percentage of Series A preferred stock received by the entity
Represents the percentage of preferred shares, issued by the equity method investee, received by the entity.
Equity Method Investment Deferred Gain (Loss)
Increase in carrying value of equity method investment
Represents the amount of gain on equity method investment which has been deferred.
Equity Method Investment Amortization Period of Deferred Gain
Period of amortization of deferred gain (in years)
Represents the period over which the gain on equity method investment will be amortized.
Furniture, fixture and equipment
Furniture Fixture and Equipment [Member]
Represents furniture, fixture and equipment of the entity.
Selling General and Administrative [Member]
Selling, general and administrative
The allocation (or location) of expenses to (in) selling general and administrative expense.
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Plan Name [Axis]
Pertinent data describing and reflecting required disclosures pertaining to an equity-based compensation arrangement, by plan.
Share-based Compensation Arrangements by Share-based Payment Award, Plan Name [Domain]
Equity-based compensation plans, including multiple equity-based payment arrangements.
Stock Option and Incentive Plan 2011 [Member]
2011 Plan
Represents the 2011 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company.
Share-based Compensation Arrangement by Share-based Payment Award Number of Plans under which No Further Awards Will be Made
Number of share-based compensation plans under which no further awards will be made
Represents the number of equity-based compensation plans under which no further awards will be made.
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Options Count Against Number of Shares Available for Grant Ratio Numerator
Numerator for the ratio of awards other than stock options counted against the total number of shares available for issuance
Represents the numerator for the ratio of awards other than stock options counted against the total number of shares available for issuance.
Share-based Compensation Arrangement by Share-based Payment Award Equity Instrument Other than Options Count Against Number of Shares Available for Grant Ratio Denominator
Denominator for the ratio of awards other than stock options counted against the total number of shares available for issuance
Represents the denominator for the ratio of awards other than stock options counted against the total number of shares available for issuance.
Award Type [Axis]
Information by award type pertaining to equity-based compensation.
Share-based Compensation Arrangement by Share-based Payment Award Options Weighted Average Exercise Price [Abstract]
Weighted Average Exercise Price
Time Vested Restricted Stock Units [Member]
Time-vested RSUs
Represents the time-vested restricted stock units awarded by the company to its employees as a form of incentive compensation.
Performance-based Restricted Stock Units [Member]
Performance-based RSU's
Represents performance based restricted stock units as awarded by a company to their employees as a form of incentive compensation.
Plan 2006 [Member]
2006 Plan
Represents information pertaining to 2006 plan.
Plan 2002 [Member]
2002 Plan
Represents information pertaining to 2002 plan.
Share-based Compensation Arrangement by Share-based Payment Award Equity Instruments Other than Options Nonvested Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value
Number of share-based compensation plans under which awards are currently made
Represents the number of equity-based compensation plans under which awards are currently made.
Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Under which Awards are Currently Made
Schedule of Marketable Securities [Axis]
Represents the number of concepts which capture the general categories of investments that may be classified as available-for-sale, held-to-maturity and trading and the information required and determined to be disclosed in relation to these categories or to additional categories or specific debt and equity investments.
Marketable Securities [Domain]
Provides the general categories of investments that may be classified as available-for-sale, held-to-maturity and trading, for which information is required or is determined to be disclosed.
Business Acquisition Cost of Acquired Entity [Table Text Block]
Schedule of purchase price of the EDT business
Disclosure of the total purchase price for the acquisition.
Schedule of Acquired Intangible Assets [Table Text Block]
Summary of intangible assets acquired
Tabular disclosure of the major classes of acquired intangible assets. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.
Elan Drug Technologies [Member]
EDT
Represents information pertaining to Elan Drug Technologies.
Business Acquisition Equity Interests Issued or Issuable Closing Price Per Share
Closing stock price (in dollars per share)
Represents the closing price per share of equity interests (such as common shares or preferred shares) issued as consideration to acquire the entity.
Business Acquisition Number of Principal Drug Technology Platforms
Number of principal drug technology platforms
Represents the number of principal drug technology platforms acquired by the entity.
Business Acquisition Pro Forma Earnings Per Share Basic and Diluted
Basic and diluted loss per common share
The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of the period.
Intangible Assets Acquired as Part of Business Combination [Table]
A table containing detailed characteristics of finite-lived and indefinite-lived intangible assets acquired during a business combination. Intangible assets are assets that have no physical form. Acquired finite-lived and indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.
Intangible Assets Acquired as Part of Business Combination [Line Items]
Intangible assets acquired
Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of operations and comprehensive loss
Derivative Instrument Gain (Loss) [Abstract]
Concentration Risk, Credit Risk [Policy Text Block]
Concentrations
Disclosure of accounting policy for credit risk.
New Accounting Pronouncements Policy [Policy Text Block]
New Accounting Pronouncements
Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting.
Cash Equivalents Original Maturity Period Maximum
Maximum original maturity period of investments classified as cash equivalents (in months)
Represents the maximum original maturity period of investments classified as cash equivalents.
Represents information pertaining to Cephalon, Inc.
Cephalon
Cephalon Inc [Member]
Represents information pertaining to VIVITROL, a product of the entity.
VIVITROL
VIVITROL [Member]
The London Interbank Offered Rate (LIBOR) used to calculate the variable interest rate of the debt instrument.
LIBOR
Debt Instrument Variable Rate Base, LIBOR [Member]
Aggregate revenues, net, during the period in the normal course of business.
Revenues, net
Revenues, Net [Member]
Defined contribution 401 (k) plan.
401 (K) Plan
Plan 401 (K) [Member]
Identification of the reference rate that is used to calculate the variable interest rate of the debt instrument.
Debt Instrument Variable Rate Base [Domain]
Name of the defined contribution plan.
Defined Contribution Benefit Plans [Domain]
Defined Contribution Plan
Represents the defined contribution plan for employees outside the reporting entity's home country.
Foreign Defined Contribution Plans [Member]
Schedule of Defined Contribution Benefit Plans Disclosures [Table]
Disclosures about defined contribution plans.
Defined Contribution Benefit Plans, Disclosure Benefit Plans [Axis]
Disclosures about defined contribution plan.
Collaborative Arrangements, Termination, Net Collaborative Profit Recognized
Net collaborative profit recognized upon termination of the collaboration
Represents the amount of net collaborative profit recognized related to the termination of the collaborative agreement.
Collaborative Arrangements, Termination Unearned Milestone Revenue
Unearned milestone revenue
Represents the amount of unearned milestone revenue recognized due to the termination of the collaborative agreement.
Collaborative Arrangements, Deferred Revenue Remaining at Termination Date
Deferred revenue remaining at the termination date
Represents the amount of deferred revenue recognized at the termination date of the collaborative agreement.
Proceeds Received to Fund Share of Product Losses for Specified Period from Termination Date
Proceeds received to fund Cephalon's share of its estimated losses during the one-year period following the termination date
Represents the amount of proceeds received from collaborative partner to fund its share of estimated product losses during the specified period from the collaborative agreement termination date.
Period Following Termination Date for Which Product Losses Funded
Period following the termination date for which Cephalon has funded its estimated losses (in years)
Represents the period following the collaborative agreement termination date for which the collaborative partner has funded its share of estimated product losses.
Revenue Recognition, Milestone Method, Revenue Recognized upon Achievement of Developmental Milestones
Revenue recognized upon the achievement of developmental milestones
The amount of consideration recognized during the period for the achievement of developmental milestones.
Revenue Recognition Milestone Method Revenue Recognized Upon Achievement of Milestones with No Remaining Performance Obligations
Revenue recognized upon the achievement of milestones with no remaining performance obligations
The amount of consideration recognized during the period for the achievement of milestones with no remaining performance obligations.
Revenue Recognition, Milestone Method, Potential Future Payments for Development Milestone
Aggregate potential future payments for development milestone
Represents the amount of potential future payments for development milestones.
Manufacturing Profit Percentage
Percentage of manufacturing profit recorded as revenue
Represents the percentage of manufacturing profit.
Threshold for Disclosure Percentage
Threshold percentage for disclosure of revenue and receivables
The minimum percentage of revenues or receivables from a single customer that is used as a threshold for disclosure of a concentration of risk.
Defined Contribution Plan, Employer Matching Contribution Percent
Percentage of employer contribution matched of the first 6% of employee pay
Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.
Defined Contribution Plan, Maximum Percentage of Participant Compensation Eligible for Employer Matching Contribution
Percentage of employee pay matched 50% by employer
Represents the maximum percentage of participants' eligible compensation for employer matching contribution.
Debt Instrument Variable Rate Base [Axis]
The alternative reference rates that may be used to calculate the variable interest rate of the debt instrument.
Vesting Rights Percentage
Vesting rights per year (as a percent)
Description of award terms as to how many shares or portion of an award are no longer contingent on satisfaction of either a service condition, market condition or a performance condition, thereby giving the employee the legal right to convert the award to shares, shown as a percentage.
Defined Contribution Benefit Plans [Line Items]
Employee benefit plans
Schedule of Share-based Compensation Arrangement by Title of Individual [Axis]
Reflects the pertinent provisions pertaining to equity-based compensation arrangement, by individual.
Schedule of Share-based Compensation Arrangement by Title of Individual with Relationship to Entity [Domain]
Title of the individual (or the nature of the entity's relationship with the individual) who is party to the equity-based compensation arrangement.
Debt Instrument Maturity Period
Term loans maturity period (in years)
Represents the maturity period of debt instrument.
Debt Instrument Variable Rate Base [Member]
Base rate
Represents the base rate used to calculate the variable rate of the debt instrument.
Debt Instrument Interest Rate Floor
Interest rate floor (as a percent)
Represents the interest rate floor for the variable rate base of the debt instrument.
Percentage of Prepayment Premium on Term Loan If Prepayment is Made in Connection with Refinancing Transaction
Percentage of prepayment premium on term loans being repaid if the prepayment is made in connection with a refinancing transaction
Represents the percentage of prepayment premium on term loans being repaid if the prepayment is made in connection with a refinancing transaction.
Percentage of Prepayment Premium of Outstanding term Loan Balance if Prepayment is Made in Connection with Amendment to Agreement Resulting in Refinancing Transaction
Percentage of prepayment premium on outstanding term loan balance if prepayment is made in connection with an amendment to the agreement resulting in a refinancing transaction
Represents the percentage of prepayment premium on the outstanding term loan balance if the prepayment is made in connection with an amendment to the agreement resulting in a refinancing transaction.
Debt Instrument Incremental Capacity Subject to Satisfaction of Certain Conditions
Incremental capacity
Represents the amount of incremental capacity available so long as the entity meets certain conditions.
Nonrecourse RISPERDAL CONSTA Secured 7 Percent Notes [Member]
Non-Recourse RISPERDAL CONSTA Secured 7% Notes
Represents the non-recourse RISPERDAL CONSTA secured notes bearing 7 percent interest rate.
Royalty Sub LLC [Member]
Royalty Sub
Represents RC Royalty Sub LLC, a former wholly-owned subsidiary of the entity.
Debt Instrument Redemption Price as Percentage of Principal Outstanding
Redemption price as a percentage of outstanding principal balance
Represents the redemption price as a percentage of outstanding principal balance of the debt instrument.
Stock Repurchase Program Additional Authorized Amount
Value of additional shares authorized under the 2007 repurchase program
The amount of additional shares authorized by the entity's board of directors under a stock repurchase plan.
Shares Acquired as Payment of Exercise Price of Stock Options Granted for Share-based Compensation
Shares acquired as payment of the exercise price of stock options granted
Represents the number of shares acquired by the entity as payment of the exercise price of stock options granted under the entity's equity compensation plans.
Shares Paid for Tax Withholding for Share-based Compensation Average Cost Per Share
Average price of shares acquired by means of net share settlements, related to the vesting of employee stock options to satisfy withholding tax obligations (in dollars per share)
Represents the cost of shares acquired by means of net share settlement of share-based awards when the employer settles the employees' income tax withholding obligation, divided by the total number of shares acquired.
Shares Acquired as Payment of Exercise Price of Stock Options Granted for Share-based Compensation Average Cost Per Share
Average price of shares acquired as payment of the exercise price of stock options granted (in dollars per share)
Represents the cost of shares acquired by the entity as payment of the exercise price of stock options granted under the entity's equity compensation plans, divided by the total number of shares acquired.
Operating Lease Term
Term of operating leases (in years)
Represents the term of the operating lease.
Operating Lease Provision for Extension of Term
Provisions for extension of lease term (in years)
Represents the provision for extension of operating lease term.
Operating Leases Future Minimum Payments Due Net of Sublease
Total future minimum lease payments
The total of future contractually required payments on leases, net of related future sublease operating rental income receivable.
Purchase Commitments [Abstract]
Purchase commitments
License and Royalty Commitment [Abstract]
License and Royalty Commitments
License Fees and Royalties Paid
Amount paid under license agreements
Represents the amount of annual license fees and royalties paid by the entity under licensing arrangements.
Deferred Tax Assets, Tax Deferred Expense Compensation and Benefits Exercise of Stock Options
Tax benefit from the exercise of stock options
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
Additional tax benefits from stock option exercises that have not been recognized
Operating Loss and Capital Loss Carryforwards
Amount of operating loss and tax credit carryforwards subject to annual limitation
Represents the annual limitation of operating loss and tax credit carryforwards, before tax effects, that may be utilized to reduce future taxable income under enacted tax laws.
Income Taxes [Table]
Disclosures pertaining to income taxes.
Income Taxes [Line Items]
Income taxes
Distribution of net loss before provision for income taxes
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Deferred Tax Assets, Tax Deferred Expense Compensation and Benefits Exercise of Stock Options Including Additional Tax Benefits
Total tax benefit from the exercise of stock options including unrecognized benefits related to the adoption of ASC 718.
The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from exercise of stock options, which can only be deducted for tax purposes when actual costs are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. This element includes the additional tax benefits from the exercise of stock options related to the adoption of ASC 718, that have not been recognized in the financial statements.
Current State and Local Tax Expense from Transfer of Intellectual Property
Provision on taxable transfer of the BYDEREON intellectual property
The component of income tax expense for the period representing amounts paid or payable as determined by applying the provisions of enacted state and local tax law to the amount of taxable transfer of intellectual property.
Current Federal Tax Benefit for Bonus Depreciation Pursuant to Small Business Jobs Act 2010
Tax benefit for bonus depreciation pursuant to the Small Business Jobs Act of 2010
The component of income tax expense for the period representing amounts refundable for bonus depreciation pursuant to the Small Business Jobs Act of 2010 as determined by applying the provision of enacted federal tax law to the domestic taxable income or loss from continuing operations.
Deferred Income Tax Benefit Increase in Fair Value of Securities
Income tax expense associated with the increase in the value of certain securities
The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to increase in fair value of securities.
Deferred Federal Income Tax Benefit in Connection with Business Combination
Tax benefit in connection with the Business Combination
The component of total income tax expense for the period comprised of an increase (decrease) during the period in the entity's domestic deferred tax assets and liabilities attributable to business combination as determined by applying the provisions of the US federally enacted tax law.
Number of business segments
Number of Business Segments
Represents the number of business segments of the entity.
Defined Contribution Plan Employee Contribution Limit as Percentage of Compensation
Employee contribution limit as a percentage of their eligible compensation
The limit of annual employee contributions to the plan, as a percentage of compensation.
Debt Instrument Required Principal Payments as Percentage of Excess Cash Flows Beginning Next Fiscal Year
Required principal payments as a percentage of excess cash flows beginning next fiscal year
Represents the amount of required principal payment as a percentage of excess cash flows beginning next fiscal year.
Debt Instrument Percentage of Loans Required to be Covered by Hedge Agreements
Percentage of aggregate principal amount of debt required to be covered under hedge agreements
Represents the percentage of aggregate principal amount of debt required to be covered under the hedge agreements.
Unrecognized Tax Benefits that would Impact Effective Tax Rate Related to Deferred tax Asset
Unrecognized tax benefit that would effect effective tax rate related to deferred tax asset
The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate, related to deferred tax assets for which full valuation allowance would be recorded.
Collaborative Arrangements Number of Units of Accounting Into which Deliverables are Separated
Number of units of accounting into which deliverables are separated
Represents the number of units of accounting into which deliverables are separated for purpose of revenue recognition under the collaborative agreement.
Operating Loss Carryback Period
Operating loss carryback period (in years)
Represents the operating loss carryback period.
Operating Loss Carryback Period Pursuant to Enacted Law
Operating loss carryback period pursuant to Worker, Homeownership and Business Act of 2009 (in years)
Represents the operating loss carryback period pursuant to enacted law.
Deferred federal and state tax benefit
The component of total income tax expense for the period comprised of the increase (decrease) during the period in the entity's domestic, state and local deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of applicable enacted tax law.
Deferred Federal, State and Local, Income Tax Expense Benefit
Nano Crystal Technology [Member]
NanoCrystal technology
The value associated with NanoCrystal technology, an intangible asset acquired from third parties.
OCR Technology [Member]
OCR technology
The value associated with OCR technology, an intangible asset acquired from third parties.
Proceeds From Sale of Rights of Licensing Manufacturing and Supply Agreement to Wholly Owned Subsidiary
Proceeds received from a wholly owned subsidiary from the sale and assignment of the rights to collect certain royalty payments and manufacturing fees
Represents the proceeds received from a wholly owned subsidiary from the sale and assignment of the rights to collect certain royalty payments and manufacturing fees earned under the license and manufacturing and supply agreements with Janssen.
Premium paid on redemption of debt
Extinguishment of Debt Premium
Represents the premium paid on the extinguishment of debt.
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type [Axis]
Pertinent data describing and reflecting required disclosures pertaining to an equity-based compensation arrangement, by award type.
Share-based Compensation Arrangements by Share-based Payment Award, Award Type [Domain]
Equity-based compensation award type, including multiple equity-based payment arrangements.
Represents the number of investments transferred into level 3 from level 1 of the fair value hierarchy.
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 1 to Level 3
Number of investments transferred into level 3 from level 1
License agreement
License Agreement [Member]
Represents information pertaining to the license agreement included under the collaboration agreement.
Manufacturing and supply agreement
Manufacturing and Supply Agreement [Member]
Represents information pertaining to the manufacturing and supply agreement included under the collaboration agreement.
Development and supplemental agreement
Development and Supplemental Agreement [Member]
Represents information pertaining to the development and supplemental agreement included under the collaboration agreement.
Development and license agreement
Development and License Agreement [Member]
Represents information pertaining to the development and license agreement included under the collaboration agreement.
License and commercialization agreement
License and Commercialization Agreement [Member]
Represents information pertaining to the license and commercialization agreement included under the collaboration agreement.
Janssen [Member]
Janssen
Represents Janssen, a collaborative partner of the entity.
Acorda [Member]
Acorda
Represents Acorda, a collaborative partner of the entity.
Amylin [Member]
Amylin
Represents Amylin, a collaborative partner of the entity.
Cilag [Member]
Cilag
Represents Cilag, a collaborative partner of the entity.
RISPERDALCONSTA [Member]
RISPERDAL CONSTA
Represents information pertaining to RISPERDAL CONSTA, a product of the entity.
INVEGASUSTENNAOrXEPLION [Member]
INVEGA SUSTENNA/XEPLION
Represents information pertaining to INVEGA SUSTENNA/XEPLION, a product of the entity.
AMPYRAOrFAMPYRA [Member]
AMPYRA/FAMPYRA
Represents information pertaining to AMPYRA/FAMPYRA, a product of the entity.
BYDUREON [Member]
BYDUREON
Represents information pertaining to BYDUREON, a product of the entity.
Collaborative Arrangement Royalty Rate
Royalty rate (as a percent)
Represents royalty as a percentage of net sales under the collaborative agreements.
Collaborative Arrangement Effective Notice Period Required to be Served for Termination of Agreement
Notice period required to be given before termination of agreement
Represents the notice period required to be served before the termination of the agreement.
Collaborative Arrangement Period after Date of First Commercial Sale of Product for Expiration of Agreement
Period after the date of the first commercial sale of the product for license expiration (in years)
Represents the period after the date of the first commercial sale of the product in a particular country that the agreement will expire.
Collaborative Arrangement Period for Resolving Default or Breach After Receipt of Notice for Termination of Agreement
Period for resolving default or breach after the receipt of notice for termination of agreement (in days)
Represents the period for resolving default or breach after the receipt of notice for termination of agreement.
Collaborative Arrangement Royalty Rate Upon Termination of Related Agreement
Royalty rate upon termination of manufacturing and supply agreement (as a percent)
Represents royalty rate upon termination of related agreement.
Collaborative Arrangement Percentage of Total Annual Requirement of Product That Can be Obtained from Second Source Manufacturer
Percentage of total annual requirement of product that can be obtained from second source manufacturer
Percentage of total annual requirement of product that can be obtained from second source manufacturer under the collaborative agreement.
Collaborative Arrangement Milestone Payment Received
Milestone payment received by the entity
Represents the amount of milestone payment received by the entity under the collaborative agreement.
Collaborative Arrangement Royalty Rate for Specified Number of Units
Royalty as a percentage of net sales from the first 40 million units
Represents royalty as a percentage of net sales of specified number of units under the collaborative arrangement.
Collaborative Arrangement Royalty Rate Beyond Specified Number of Units
Royalty as a percentage of net sales beyond the first 40 million units
Represents royalty as a percentage of net sales beyond specified number of units under the collaborative agreement.
Collaborative Arrangement Number of Units Sold Threshold for Determination of Royalty Rate
Threshold for number of units sold used to determine royalty rate
Represents the threshold for the number of units sold which is used to determine the royalty rate under the collaborative agreement.
Collaborative Arrangement Additional Milestone Payments Eligible Upon Receipt of Regulatory Approvals
Amount of additional milestone payments eligible upon receipt of regulatory approvals for the product
Represents the amount of additional milestone payments eligible upon receipt of regulatory approvals for the product under the collaborative agreement.
Collaborative Arrangement Period after Effective Date for Right to Terminate Agreement
Number of years after the effective date of the agreement, which gives Cilag a right to terminate the agreement
Represents the period after the effective date of the agreement, which gives the counterparty a right to terminate the agreement.
Collaborative Arrangement Effective Notice Period Required to be Served for Termination of Agreement Due to Change in Pricing and Reimbursement
Notice period required to be given before termination of agreement due to change in pricing and/or reimbursement (in days)
Represents the notice period required to be served before the termination of the agreement due to change in pricing and reimbursement.
Collaborative Arrangement Extension Period for Resolving Default or Breach after Receipt of Notice for Termination of Agreement
Extension period for resolving default or breach after the receipt of notice for termination of agreement (in days)
Represents the extension period for resolving default or breach after the receipt of notice for termination of agreement.
Schedule of Property, Plant and Equipment Components [Table Text Block]
Tabular disclosure of the components of property, plant and equipment.
Schedule of property, plant and equipment
License and Collaboration Agreement and Supply Agreement [Member]
Represents information pertaining to the license and collaboration agreement and supply agreement.
License and collaboration agreement and supply agreement
Countries [Axis]
Represents information pertaining to all countries.
All Countries [Domain]
UNITED STATES
United States
U.S
IRELAND
Ireland
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers into Level 3 from Level 1
Investments transferred into Level 3 from Level 1
Transfers into assets measured at fair value from Level 1 and categorized within Level 3 of the fair value hierarchy that have taken place during the period.
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers into Level 3 from Level 2
Investments transferred into Level 3 from Level 2
Transfers into assets measured at fair value from Level 2 and categorized within Level 3 of the fair value hierarchy that have taken place during the period.
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out of Level 3 to Level 2
Investments transferred out of Level 3 To Level 2
Transfers out of assets measured at fair value and categorized within Level 3 of the fair value hierarchy that have taken place during the period to level 2.
Indefinite-lived Intangible Assets Excluding Goodwill Gross
Gross carrying amount
Gross amount of assets (excluding financial assets) that lack physical substance, excluding goodwill, having a projected indefinite period of benefit.
Indefinite Lived Intangible Assets, Excluding Goodwill, Accumulated Impairment Loss
Accumulated Amortization
The accumulated impairment losses as of the balance sheet related to intangible assets, excluding goodwill, having a projected indefinite period of benefit.
Intangible Assets, Net Excluding Goodwill Accumulated Amortization and Impairment Loss
Accumulated Amortization
The accumulated amortization and impairment losses related to intangible assets, excluding goodwill as of the balance sheet date.
Geographic Information [Policy Text Block]
Geographic Information
Disclosure of the entity's accounting policy for geographic information.
Defined Contribution Plan, Maximum Employee Contribution Limit As Percentage of Total Taxable Earnings
Maximum employee contribution limit as a percentage of their total taxable earnings
The limit of annual employee contributions to the plan, as a percentage of their total taxable earnings.
Defined Contribution Plan, Annual Contribution by Per Employee Amount
Per employee contribution limit
Maximum amount per employee, by the terms of the plan, that the employee may contribute to a defined contribution plan.
Revenue Recognition Milestone Method Substantive Amount of Future Potential Payments to be Recognized as Milestones Achieved
Substantive amount of future potential payments that are expected to be recognized as revenue when milestones are achieved
Represents the substantive amount of future potential payments that are expected to be recognized as revenue when milestones are achieved.
Stock Option and Incentive Plan 2008 [Member]
2008 Plan
Represents the 2008 Stock Option and Incentive Plan which provides for issuance of non-qualified and incentive stock options, restricted stock, restricted stock units, cash-based awards and performance shares to employees, officers and directors of, consultants to the company.
Schedule of Net Income (Loss) Before Provision for Taxes by Geographical Area [Table Text Block]
Schedule of net loss before provision for income taxes by geographical area
Tabular disclosure of net income or loss before provision for income taxes by geographical area of the entity.
Reversal of Deferred Tax Liability Relating to Acquired Intellectual Property
Tax benefit from partial release of the Irish deferred tax liability related to acquired intellectual property
Represents the tax benefit from partial release of the deferred tax liability related to acquired intellectual property created in connection with business combination.
Unremitted Earnings of Foreign Subsidiaries
Cumulative unremitted earnings of overseas subsidiaries
Represents the cumulative unremitted earnings of overseas subsidiaries as of the end of the period.
Operating Loss and Tax Credit Carryforwards Annual Limitation
Amount of operating loss and tax credit carryforwards subject to annual limitation.
Represents the annual limitation of operating loss and tax credit carryforwards, before tax effects, that may be utilized to reduce future taxable income under enacted tax laws.
Percentage of employer contribution matched up to the first 5% of employee pay
Percentage of employees' gross pay for which the employer contributes a matching contribution up to the first 5 percent of employee pay to a defined contribution plan.
Defined Contribution Plan, Employer Matching Contribution Percent for UpTo First 5 Percent of Employee Pay
Percentage of employee pay matched 100% by employer
Represents the maximum percentage of participants' eligible compensation for employer 100 percent matching contribution.
Defined Contribution Plan, Maximum Percentage of Participant Compensation Eligible for Employer 100 Percent Matching Contribution
Minimum Period after Loss, Carryforwards Utilized that Tax Returns Remain Open to Examination
Represents the minimum period after loss carryforwards have been utilized that tax returns remain open to examination.
Minimum period after loss carryforwards utilized that tax returns remain open to examination (in years)
Maximum Period after Loss Carryforwards Utilized that Tax Returns Remain Open to Examination
Represents the maximum period after loss carryforwards have been utilized that tax returns remain open to examination.
Maximum period after loss carryforwards utilized that tax returns remain open to examination (in years)
Number of investments transferred into level 3 from level 2
Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Number of Investments Transfers from Level 3 to Level 2
Represents the number of investments transferred into level 3 from level 2 of the fair value hierarchy.
Defined Contribution Plan Employer Matching Contribution Percent, Maximum
Maximum percentage of employer contribution matched of employee's taxable earnings
Maximum percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.
Research and Development Arrangement Related to Three Elan Drug Technologies [Member]
IPR&D related to three EDT
Represents information pertaining to in-process research and development related to Elan Drug Technologies.
Number of Products
Number of products
Represents the number of products.
Gain on foreign currency translation
Foreign Currency Transaction Gain (Loss), before Tax
Current income tax provision (benefit)
Current Income Tax Expense (Benefit)
Internal Revenue Service IRS Member and State and Local Jurisdiction [Member]
Federal, State, and Local
Represents the designated tax departments of the United States of America and state and local government entitled to levy and collect income taxes from the entity.
Alkermes Europe Ltd [Member]
Alkermes Europe Ltd
Represents information pertaining to Alkermes Europe, Ltd.
Deferred Tax Assets Operating Loss Carry forwards
NOL carryforwards
Foreign rate differential
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential
Receipt of Company Stock in Shares to Satisfy Withholding Tax Obligations
This element represents receipt of Alkermes' stock shares acquired to satisfy tax withholding obligations.
Net share settlements of ordinary shares to satisfy withholding tax obligations
Deferred Tax Liability Related to Acquired Intellectual Property
Represents the deferred tax liability related to acquired intellectual property.
Deferred tax liability related to acquired intellectual property